2024年医药行业分析报告(1) VIP专享VIP免费

此资料由网络收集而来，如有侵权请告知上传者立即删除。资料共分享，我们负责传递知识。2020年医药行业分析报告篇一：2020年医药行业现状及发展趋势分析报告(此文档为word格式，可任意修改编辑！）2020年3月正文目录一、近年医药行业回顾........................................................................................51.1医药行业运行情况.........................................................................................51.2板块比较优势明显.......................................................................................121.3医药板块市场表现及估值情况...................................................................13二、三医联动，推进医改进程..........................................................................182.1医保：控费压力不减，调控将是常态.......................................................182.2医药：研发、流通全方位提质增效...........................................................192.3医疗：公立医院改革将全面推行...............................................................26三、机遇挑战并存，精选细分领域和个股......................................................281此资料由网络收集而来，如有侵权请告知上传者立即删除。资料共分享，我们负责传递知识。3.1需求端变化：婴幼儿、慢性病用药有望迎来高速增长...........................283.2仿制药一致性评价+政策扶持+医保支付标准受益投资标的..................333.3医保目录调整受益标的...............................................................................343.4两票制将全国推行，流通领域集中度提升大势所趋...............................35四、主要公司分析..............................................................................................364.1恩华药业.......................................................................................................364.2信立泰...........................................................................................................374.3长春高新.......................................................................................................374.4丽珠集团.......................................................................................................384.5恒瑞医药.......................................................................................................394.6华东医2此资料由网络收集而来，如有侵权请告知上传者立即删除。资料共分享，我们负责传递知识。药.......................................................................................................394.7九州通...........................................................................................................404.8羚锐制药.......................................................................................................404.9亿帆医药.......................................................................................................41图目录图1：国内医保基金收入、支出及增速情况......................................................6图2：近年国内医药工业收入及增速情况..........................................................6图3：近年国内医药工业利润及增速情况..........................................................7图4：化学制药行业收入、扣非净利润及增速情况..........................................8图5：中药行业收入、扣非净利润及增速情况..................................................8图6：生物制品行业收入、扣非净利润及增速情况..........................................9图7：医疗器械行业收入...